Arcus Biosciences
RCUS
15.62
-0.16
-1.01%
Arcus Biosciences
US · RCUS
#2467 by market cap
Listed 2018
15.62
-0.16
-1.01%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:39
About Arcus Biosciences
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
- Founded
- 2015
- CEO
- Dr. Terry Rosen, PhD
- Employees
- 601
- Headquarters
- Hayward, California, United States of America
- Fiscal year end
- 12-31
- Website
- arcusbio.com
Company profile
- Exchange
- US
- Symbol
- RCUS
- Market-cap rank
- #2467
- Listing date
- 2018-03-15
- Market cap
- 2.25B
- Float cap
- 1.67B
- Shares out
- 143.99M
- Float shares
- 107.19M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 19:39:06 · For reference only, not investment advice and not tailored to your situation.
Arcus Biosciences discussion 0 comments